New England Life Science & Biotech Summit

The New England Life Science & Biotech Summit, presented in collaboration with Marcum and CBIA, explored the dynamic landscape of early growth and late-stage life science and biotech companies.

The event featured a range of speakers, including Angela Hwang, Pfizer’s chief commercial officer and president of its global biopharmaceuticals business, who talked with Connecticut Bioscience Growth Council executive director Paul Pescatello.

Panel discussions included industry leaders and visionaries from organizations like Yale University, United Healthcare, Cigna Healthcare, Hartford HealthCare, and Janney Montgomery Scott.

Agenda

1 pm | Check-In & Networking

1:55 pm | Opening Remarks

• Chris DiPentima, President & CEO, CBIA
• Michael Brooder, National Technology & Life Sciences Leader, Marcum LLP

2 pm | The BioTech Innovation Landscape

• Angela Hwang, Pfizer’s chief commercial officer and president of its global biopharmaceuticals business, talks with Connecticut Bioscience Growth Council executive director Paul Pescatello.

2:45 pm | Transforming Biotech in Connecticut

• Moderator: Dan Wagner, Senior Managing Director, Investments, Connecticut Innovations
• State Senator Christine Cohen (D-Guilford)
• Josh Geballe, Senior Associate Provost for Entrepreneurship & Innovation, Yale University
• State Senator Tony Hwang (R-Fairfield)

3:30 pm | Healthcare Innovations

• Tim Archer, CEO, New England Health Plan, United Healthcare
• Jim O’Brien, Vice President, Network & Benefits Solutions, Cigna Healthcare
• Lee Schwamm, Associate Dean, Digital Strategy & Transformation, Yale School of Medicine; SVP & Chief Digital Health Officer, Yale New Haven Health System
• Barry Stein, Chief Clinical Innovation Officer & Chief Medical Informatics Officer, Hartford HealthCare

4:15 pm | Capital Markets & the Economy

• David Allebach, Managing Director, Corporate Advisory Group Head, Janney Montgomery Scott 
• Mark Luschini, Chief Investment Strategist, Janney Montgomery Scott; President & Chief Investment Officer, Janney Capital Management
• David Reed, Managing Director, Investment Banking, Janney Montgomery Scott

4:45 pm | Networking Reception